ARS Pharmaceuticals, Inc. SPRY Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$171.3M-2,242% | $8M+115% | -$54.37M-56.8% | -$34.68M— | ||
| $1.37M+1,630% | $79K+8.2% | $73K— | —— | ||
| $22.1M+52.0% | $14.53M+57.4% | $9.24M+58.1% | $5.84M— | ||
| -$170.87M-1,361% | $13.55M+123% | -$59.27M-47.9% | -$40.08M— | ||
| $339K-39.8% | $563K— | —— | $199K— | ||
| —— | —— | —— | -$199K— | ||
| $104.6M+44.5% | $72.4M+949% | $6.9M-96.4% | $190.73M+259% | ||
| -$9.5M— | —— | —— | $150.46M+323% | ||
| -$171.21M-1,418% | $12.99M+122% | -$59.44M-47.6% | -$40.28M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ARS Pharmaceuticals, Inc. generate?
- ARS Pharmaceuticals, Inc. (SPRY) generated -$175.1M in operating cash flow over the trailing twelve months.
- What is ARS Pharmaceuticals, Inc.'s free cash flow?
- After $248.0K of capital expenditures, ARS Pharmaceuticals, Inc.'s free cash flow was -$175.3M over the trailing twelve months, down 732.7% year over year.
- Where does ARS Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from ARS Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
